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UNIVERSALITY OF J-SHAPED AND U-SHAPED DOSE-RESPONSE RELATIONS
AS EMERGENT PROPERTIES OF STOCHASTIC TRANSITION SYSTEMS
Louis Anthony (Tony) Cox, Jr.  Cox Associates and University of Colorado,
Denver, CO
 Dose-response data for many chemical carcinogens exhibit multiple apparent concen-
tration thresholds. A relatively small increase in exposure concentration near such a
threshold disproportionately increases incidence of a specific tumor type. Yet, many com-
mon mathematical models of carcinogenesis do not predict such threshold-like behavior
when model parameters (e.g., describing cell transition rates) increase smoothly with
dose, as often seems biologically plausible. For example, commonly used forms of both the
traditional Armitage-Doll and multistage (MS) models of carcinogenesis and the
Moolgavkar-Venzon-Knudson (MVK) two-stage stochastic model of carcinogenesis typical-
ly yield smooth dose-response curves without sudden jumps or thresholds when exposure
is assumed to increase cell transition rates in proportion to exposure concentration.
This paper introduces a general mathematical modeling framework that includes the
MVK and MS model families as special cases, but that shows how abrupt transitions in can-
cer hazard rates, considered as functions of exposure concentrations and durations, can
emerge naturally in large cell populations even when the rates of cell-level events increase
smoothly (e.g., proportionally) with concentration. In this framework, stochastic transi-
tions of stem cells among successive events represent exposure-related damage. Cell pro-
liferation, cell killing and apoptosis can occur at different stages. Key components include:
1. An effective number of stem cells undergoing active cycling and hence vulnerable to
stochastic transitions representing somatically heritable transformations. (These need
not occur in any special linear order, as in the MS model.)
2. A random time until the first malignant stem cell is formed. This is the first order-sta-
tistic, T = min{T1, T2, . . . , Tn} of n random variables, interpreted as the random
times at which each of n initial stem cells or their progeny first become malignant.
3. A random time for a normal stem cell to complete a full set of transformations con-
verting it to a malignant one. This is interpreted very generally as the first passage time
through a network of stochastic transitions, possibly with very many possible paths and
unknown topology.
In this very general family of models, threshold-like (J-shaped or multi-threshold) dose-
response nonlinearities naturally emerge even without cytotoxicity, as consequences of sto-
chastic phase transition laws for traversals of random transition networks. With cytotoxic-
ity present, U-shaped as well as J-shaped dose-response curves can emerge. These results
are universal, i.e., independent of specific biological details represented by the stochastic
transition networks.
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sharp transition threshold
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1. INTRODUCTION AND MOTIVATION
What is the least amount of knowledge about carcinogenic processes
needed to predict their corresponding dose-response relations?
Historically, some of the most widely applied dose-response models have
been based on very simple, generic postulates about carcinogenesis. For
example, the linearized multistage model that dominated regulatory risk
assessment of carcinogens in the US for many years is based on the
Armitage-Doll conceptual model of cancer (e.g., Brown and Chu, 1987),
in which originally “normal” stem cells undergo somatically heritable
transformations, eventually producing a fully malignant cell that can
develop into a clinically observed cancer after some delay, unless death
from other causes occurs first. The more recent Moolgavkar-Venzon-
Knudson (MVK) two-stage stochastic model of carcinogenesis emphasizes
two rate-limiting transformations, from “Normal” to “Initiated” (also
called “pre-malignant”) and from “Initiated” to “Malignant”, while incor-
porating proliferation and cell death of initiated cells at rates that can
depend on exposures. In both models and several variations (e.g., Little
et al., 2002), exposure can also affect the transformation rates taking cells
at each stage to the next. 
Such models have been popular in part because they lead to para-
metric families of dose-dependent, age-specific hazard functions for can-
cer that can be fit to many epidemiological and rodent cancer bioassay
data sets without having to understand all the details of how transforma-
tions take place, or even necessarily what specific cell populations corre-
spond to each model stage. Exposure and tumor data suffice for fitting
the models. On the other hand, the same models provide clear biological
interpretations and explanations for much experimental evidence,
including initiation-promotion-progression experiments in which apply-
ing carcinogens over time in different orders creates very different car-
cinogenic responses, essentially because creating initiated cells before
amplifying them with a promoter that stimulates their proliferation, or
completing their transformation to malignancy with a progressor, is far
more effective in producing tumors than reversing this order.
The conceptual value and practical successes of these stochastic tran-
sition models can often be increased by making modifications to capture
important phenomena observed in epidemiology and experimental car-
cinogenesis. Among these are:
• Importance of proliferation of normal cells in increasing cancer risks
(Holt, 1997 for radiation). Many chemical carcinogens have been
found to increase tumor rates in experimental animals only in situa-
tions that also cause cytotoxicity and regenerative hyperplasia or com-
pensating proliferation of apparently normal cell populations in re-
sponse to the toxic injury. Examples include chloroform, diesel
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exhaust, formaldehyde, and many others. When such compensating
proliferation is a prerequisite for chemically induced carcinogenesis,
traditional linearized multistage modeling may over-estimate risks at
low concentrations by more than five orders of magnitude (Larson et al.,
1996), or predict significant risks at low concentrations even if none
truly exists (Constan et al., 2002). Thus, dose-response models that ac-
count for the role of normal stem cell proliferation and kinetics follow-
ing cytotoxic damage may be needed to obtain realistic risk estimates
for some chemicals.
• Carcinogenic thresholds in dose rate (e.g., concentration for inhaled lung
carcinogens) and/or duration of exposure
Table 1 illustrates the idea of carcinogenic thresholds with experi-
mental data for isoprene. Liver and lung adenomas and carcinomas are
only significantly elevated at concentrations above 70 ppm. In this data
set, 140 ppm is the smallest concentration for which significant increases
were observed. Similarly, histiosarcomas exhibit an apparent response
threshold between 140 and 280 ppm. These thresholds are specific to
concentration, rather than to cumulative exposure. For example, dou-
bling concentration (from 70 ppm to 140 ppm between exposure groups
3 and 5) increases liver adenomas from 0.29 to 0.44, whereas, doubling
weeks of exposure (from 40 to 80 between exposure groups 3 and 4) does
not increase risk significantly at any site, and even appears to reduce it.
Similarly, quadrupling exposure concentration from 70 ppm to 280 ppm
while quartering exposure duration from 80 weeks to 20 weeks unam-
biguously increases tumor risk (compare exposure groups 4 and 6), even
though cumulative exposures are identical. 
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TABLE 1 Results of a stop-exposure experiment for Isoprine in male B6C3F1 mice
Group ppm weeks hr/day
Liver 
adenomas
Lung 
adenomas
Other 
adenomas
Liver car-
cinomas
Lung car-
cinomas
Histio-
sarcomas
1 0 0 8 0.22 0.22 0.14 0.18 0 0
2 10 80 8 0.24 0.32 0.12 0.12 0.02 0.04
3 70 40 8 0.29 0.16 0.30* 0.22 0 0.04
4 70 80 8 0.30 0.08 0.18 0.18 0.04 0.04
5 140 40 8 0.44* 0.20 0.28* 0.20 0.02 0.02
6 280 20 8 0.36 0.32 0.36* 0.24 0.06 0.16*
7 2200 80 4 0.42* 0.30 0.56* 0.30 0.06 0.14*
8 2200 40 8 0.57* 0.59* 0.65* 0.37* 0.06 0.14*
Explanation: Columns 2–4 summarize the exposures defining each dose group. The remaining
columns show the fraction of animals in each dose group that were found to have each tumor type at
necropsy. Source: Cox LA Jr, Bird MG, Griffis L. Isoprene cancer risk and the time pattern of dose
administration. Toxicology. 1996 Oct 28;113(1–3):263–72. 
* Tumor incidence rates in bold and marked with an asterisk are significantly greater than in the con-
trol group (p < 0.05 by Fisher’s Exact Test).
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Apparent carcinogenic thresholds or threshold-like nonlinearities
can also exist for components of exposure duration. For example, at
higher concentrations, doubling hours-per-day of exposure while halving
weeks of exposure increases the risk of adenomas and liver carcinomas
(compare exposure groups 7 and 8), even though cumulative exposures
remain identical.
Such threshold-like behavior for exposure concentrations and dura-
tions occurs for many chemical carcinogens. It requires explanations that
go beyond the usual multistage and MVK stochastic transition models
with linear-in-dose transition rates, since both of those models predict
that risk changes smoothly with the concentration and duration of inter-
nal doses received by target tissues or cell populations. Physiologically-
based pharmacokinetic (PBPK) modeling shows that these internal dose
attributes, in turn, are typically smooth (and, at low doses, approximate-
ly linear) functions of the concentration and duration of administered
dose over the range of experimental data, even though induction, deple-
tion, or saturation of enzyme-mediated processes can introduce impor-
tant non-linearities at very high administered doses. 
To better understand how threshold-like nonlinearities can occur at
experimental or low doses even without nonlinearities in the PBPK com-
ponent, this paper reexamines the mathematical foundations of sto-
chastic transition models of carcinogenesis and discusses how natural
(smooth, possibly linear no-threshold) dose-response relations at the
level of individual cells can lead to the sharp transitions and threshold-
type behaviors observed in some empirical dose-response relations for
aggregate cell populations. 
2. DETERMINISTIC THRESHOLDS IN STOCHASTIC TRANSITION SYSTEMS
The Symmetric Multistage Model
To build intuition, let us first consider a symmetric multistage model as
follows: A cell line gradually accumulates transformations (e.g., somati-
cally heritable mutations) from a set of K possible transformations.
Transformations occur randomly and independently over time, i.e.,
each of the K transformations arrives according to an independent
Poisson process, with (at least approximately) equal intensities, given by
λ average occurrences per unit time for each of the K distinct transfor-
mations. (Transformations with intensities that are much greater than
this common minimum value are not rate-limiting, and may be disre-
garded. Once any of the K transformations has occurred, we assume
that it is permanent and irreversible. If a specific transformation occurs
more than once, the occurrences after the first one are wasted, i.e., the
cell genotype has already acquired that transformation and does not
reach malignancy any quicker if it occurs again.) The cell line survives
L. A. Cox
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for a finite lifetime of duration T. If all K distinct transformation occur
before time T, then the cell line becomes malignant. Under these con-
ditions, what is the probability that the cell line will become malignant
before death at time T? And, if it does become malignant before time
T, then what is the probability distribution for the time at which the first
malignant cell is formed? 
The somewhat surprising answer is that, for sufficiently large K, there
is a “sharp transition” time such that the first malignant cell is very unlike-
ly to be formed much sooner or much later than that time. In other
words, a nearly deterministic occurrence time for the first malignant cell
emerges simply as a consequence of there being many stages in this sim-
ple stochastic transition model. 
THEOREM 1: In the completely symmetric multistage model, there
is a “sharp transition” time* [given to a close approximation by T* ≈
(1/λ)((ln(K) + γ), where λ is the expected number of transformations
events per unit time, i.e., their average occurrence rate; and γ = Euler’s
constant = 0.57721 . . . ] such that: (a) The expected time until the first
malignant cell is formed is T*; and (b) the coefficient of variation of the
actual (random) time of formation of the first malignant cell, i.e., the
ratio of its standard deviation to T*, approaches 0 for large K.
Proof: The expected number of transformation occurrences,
including wasted (i.e., repeated) ones, until a malignant cell is formed
(i.e., until all K transformations have occurred at least once) is given by
the harmonic sum: E(n*) = K(1 + 1/2 + 1/3 + . . . + 1/K) ≈ K((ln(K)
+ γ), where n* denotes the random number of the transformation
occurrence event at which all K transformations are first completed and
γ is Euler’s constant, γ = 0.57721. . . . This follows from previously
known results for the “Coupon Collector’s Problem” with equal
probabilities (e.g., Ross, 1996 p. 414; or Motwani and Raghavan, 1995)
or for the maximum of K independent exponential random variables
(e.g., Nelson, 1995, page 173). (Intuitively, it is motivated by the fact that
any of the K transformations can occur first and be non-redundant, after
which the probability that the next transformation is non-redundant
drops to (K – 1)/K, then to (K – 2)/K, . . . , and finally, for the last
transformation, to 1/K.) The expected time until a malignant cell is
formed is therefore T* = E(t*) = E(n*)/(Kλ) ≈ (1/λ)((ln(K) + γ) where
t* denotes the random time at which all K transformations are first
completed and Kλ is the rate at which transformations events arrive
(since each of K types independently arrives at rate λ.) This proves part
(a) of the theorem. That the probability distribution of n* has a sharp
concentration around E(n*) is proved in Motwani and Raghavan, 1995.
Given this key result, hold n* fixed. The time until n* transformations
Universality of J-shaped and U-shaped Dose Response Relations as Emergent Properties
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(including redundant ones) have occurred has a gamma distribution
with mean n*/(Kλ) and variance n*/(K2λ2), by a standard results for
waiting times in Poisson arrival times and for the mean and variance of
the gamma distribution (e.g., Ross, 1996, p. 18). The ratio of the
standard deviation to the mean of this waiting time is therefore (n*)–1/2
( [K((ln(K) + γ)]–1/2, yielding part (b).
An interesting, and perhaps unexpected, aspect of this result is that it
establishes a form of nearly deterministic behavior for a stochastic system:
if the sharp transition time T* is smaller than the death time T, then for-
mation of a malignant cell by time T is almost certain; otherwise, it is very
unlikely. (This qualitative behavior is typical of what is sometimes called a
0–1 law in stochastic processes.) If K is not large enough to guarantee a
sharp transition at time T*, then the qualitative behavior can be general-
ized as follows: for any ε > 0, no matter how small, there is an interval of
times [T–, T+] such that the probability of a malignant cell being formed
before T– or after T+ is less than ε, i.e., the cumulative probability distri-
bution for the occurrence time of the first malignant cell increases from
almost 0 to almost 1 over this interval. As K increases, the width of this
interval shrinks toward zero, with T– and T+ approaching a common
value, T*. 
In this simple model, exposure to carcinogens can increase cancer
risk either by increasing λ or by decreasing K (in effect, by completing
some transformations relatively quickly, so that they are removed from
the rate-limiting set). Either reduces T*, making formation of malignant
cells prior to death of the cell line more likely. If the effect of a carcino-
genic exposure is to reduce K, the number of remaining transformations
required to reach malignancy, then the lifetime probability of tumor,
Pr(T* < T), will increase in discrete steps (corresponding to transforma-
tions completed and no longer on the critical path) that may be insensi-
tive to the detailed exposure pattern used to reduce K.
Generalizations 
Of course, the symmetric multistage model is not realistic as a gen-
eral model of carcinogenesis. Initiation-promotion experiments have
established that there is asymmetry in the set of changes leading from
normal to malignant cells, with initiation changes preceding progression
stages. However, the symmetric case illustrates some ideas that hold
more generally.
Let x(t) = [x1(t), x2(t), . . . , xK(t)] denote the “state” of a cell at time
t, with xj(t) = 1 if some specific fact j is true of the cell at time t and xj(t) =
0 otherwise. Thus, the Boolean vector x(t) indicates which facts are true
of the cell at time t. Let F(x) be a monotonically increasing 0-1 function of
x, with F(0) = F(0, 0, . . . , 0) = 0 and F(1) = F(1, 1, . . . , 1) = 1, indi-
cating whether some global property holds for the cell. This might be a
L. A. Cox
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property such as that it has previously reached the “initiated” stage, that it
has died, or that it has become malignant. (Although a cell can make a
transition from initiated to malignant, we model this as setting the bits for
“reached initiated” and “reached malignant” from (1, 0) to (1, 1) respec-
tively, to preserve the convention that the cell only makes irreversible tran-
sitions among monotonically increasing states.) The facts are described
(“oriented”) in such a way that having more of them true never decreases
the value of F(x), while F(x) = 0 when none of the facts in x is true and
F(x) = 1 when all of the facts in x are true. For example, x might indicate
which transformations leading from a normal stem cell to a malignant cell
have taken place. In this family of models, the global property of interest
is assumed to be determined by the truth values of the finite set of facts
summarized in x. Finally, suppose that x(t) increases monotonically
(although, perhaps, randomly) over time, i.e., x(t + s) ≥ x(t) for any s ≥ 0
(where the inequality holds component by component), so that facts that
once become true remain true thereafter. This captures the idea of irre-
versible transformations, e.g., somatically heritable mutations. 
THEOREM 2: (a) If F(x) is a monotone function of a Boolean 
K-vector x with F(0) = 0 and F(1) = 1, and if x(t) increases monotonically
with time from x(0) = (0, 0, . . . , 0) = 0 to x(t) = (1, 1, . . . , 1) = 1 for
all sufficiently large t then for any ε > 0, no matter how small, there is a
finite transition interval of times [T–, T+] such that Pr(F(x(t) = 1) ≤ ε for all
t ≤ T– and Pr(F(x(t) = 1) ≥ 1 – ε for all t ≥ T+. In other words, the
probability that F(x(t)) = 1 (i.e., that the global property of interest holds)
increases from almost 0 before T– to almost 1 by T+. (Moreover, the ratio
T+/T– is bounded by a finite constant that depends only on ε.) (b) If F(x)
is also a symmetric function of its arguments and all facts have the same
probability densities for the random times at which they become true,
then the width of the transition interval is T+ – T– = c/ln(K), where c is a
constant that depends only on ε. This width approaches zero for large K,
i.e., the transition time has a sharp threshold.
Proof: Part (a) follows from a theorem of Bollobas and Thomason,
1986, also discussed by Friedgut and Kalai, 1996, p. 2994, upon replacing
identical probabilities for each Pr(xj = 1) with monotonically increasing
functions of time between Pr(xj = 1) = 0 at time 0 and Pr(xj = 1) = 1 at some
later time. This guarantees that K times tj can be found such that all
Pr[xj(tj) = 1] are equal, allowing the theorem of Bollobas and Thomason,
1986 to be applied. Part (b) is a reinterpretation of a sharp threshold
result proved as Theorem 2.1 by Friedgut and Kalai, 1996. 
Example: Mitotic Spindle Poison Thresholds
As a practical application, consider the probability that a specific cell
undergoes mitotic spindle disruption leading to aneuploidy during mito-
Universality of J-shaped and U-shaped Dose Response Relations as Emergent Properties
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sis in the presence of an aneugen. If at least some large number, K, of tar-
get sites (e.g., sulfhydryl groups on tubulin) must be bound by reactive
metabolite molecules (e.g., p-benzoquinone, for benzene) during mitosis
to disrupt spindle formation, and if metabolite molecules arrive at an
average rate per site per minute that is proportional to their concentra-
tion in the target tissue, then part (b) of Theorem 2 implies that disrup-
tion will occur with high probability in the required time window if and
only if the concentration is sufficiently great. (Interpret x(t) as the vector
indicating which sites have been bound by time t.) In effect, there will be
a critical concentration below which disruption does not occur and above
which it occurs almost certainly.
Example: Receptor-Mediated Response Thresholds
Suppose that a cell has a large number of cell surface receptors, of
which at least K must be bound simultaneously by ligand molecules (per-
haps a chemical from an environmental source that mimics a natural cell
signaling molecule) in order to trigger a particular response. Let c
denote the average concentration of ligand molecules in the cell’s envi-
ronment, starting at time t = 0 and ending at time T, with concentration
equal to zero outside this exposure interval. For simplicity, express c in
units of expected arrivals of molecules at receptor sites per unit time. Let
pj(t) = 1 – exp
–ct be the corresponding probability that receptor j has
become bound by time t. (Thus, pj(t) is the expected value of xj(t), where
xj(t) = 1 if receptor j has become bound by time t, else xj(t),= 0. We
assume that binding times are relatively long, and so may be interpreted
as being “irreversible” for purposes of this analysis.) Then x(t) summa-
rizes which receptors have become bound by time t; F(x(t)) = 1 if this
number exceeds K and is 0 otherwise, indicating whether a cell-level
response has been triggered; and part (b) of Theorem 2 implies that for
large K and fixed T, the probability of triggering a cell response will be
close to 0 for all concentrations below some critical concentration, c*,
and will be close to 1 for concentrations greater than c*. 
Actually, in this case, it is the area-under-curve (AUC) product (c x T)
that matters: for large K, the response probability undergoes a sharp tran-
sition from 0 to 1 as AUC = cT increases past some threshold level AUC*.
For a fixed exposure duration, such as T = 4 hours per day, the critical
concentration is: c* = AUC*/T. If exposure occurs once per day for some
number of hours of duration, with full recovery between consecutive
days, then this simple model predicts that doubling the hours-per-day of
exposure for a fixed concentration might have a relatively large effect (if
2cT > AUC* but cT < AUC*), while doubling the total number of days of
exposure to the original concentration might have no effect (if cT <
AUC* on each day). This is similar to the lung adenoma response
between groups 7 and 8 in Table 1, which roughly doubles when hours-
per-day of exposure is doubled and number of days of exposure is halved.
L. A. Cox
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Of course, any such critical AUC-per-day threshold, AUC*, would pre-
sumably provide at best only part of the explanation for lung adenomas,
as other mechanisms, such as compensating proliferation in response to
cytotoxic damage, can also be important. Even if such a threshold for
AUC-per-day does exist, it need not have anything to do with receptor-
mediated responses, as many other phenomena also might satisfy the con-
ditions of Theorem 2 and produce sharp transition intervals. 
Example: Compensating Proliferation Thresholds
Suppose that the stem cells in an unstressed tissue are on average
equally likely to self-renew (adding a net of one new stem cell) or to dif-
ferentiate into two non-stem daughter cells (subtracting a net of one stem
cell). When the stem cell population becomes depleted by cytotoxicity or
other means, the stem cell proliferation rate increases to a maximum,
e.g., with a 0.6 probability of renewal vs. only 0.4 of differentiation. This
maximum stimulation to proliferate occurs if and only if the stem cell
population is depleted by at least a certain fraction of its normal value,
say, K/N, where N is the normal size and K is the number that must be
simultaneously absent to achieve maximum stimulation. If a brief cyto-
toxic dose kills or removes each stem cell with probability p, then
Theorem 2 (with x(t) summarizing which stem cells remain and which
have been removed) implies that maximum compensating proliferation
will occur if and only if p is greater than some critical value, p*. (Of
course, partial compensation may occur at lower doses that remove fewer
than K stem cells.)
In general, Theorem 2 applies to many settings in which occurrence
of a global outcome or property requires that at least K independent
events must occur within some time window of length T. If the probabili-
ty of each event occurring by time T is p (which may depend on exposure
concentration or more generally on exposure history over the interval
from t = 0 to t = T), and if the number of events K is large, then the glob-
al outcome is almost certain to occur if p is greater than some critical
value p*, and otherwise is almost certain not to occur. This threshold
property does not depend on the nature of the events: it is a universal
property of systems with properties that can be described by monotone
symmetric functions of K independent Bernoulli (0-1) random variables. 
Example: Transformations with Precedence Constraints: Event Trees and
Transition Networks
A useful generalization of many multistage models is to allow for
more than one possible sequence of events (e.g., somatically heritable
transformations, epigenetic events) leading from normalcy to malignan-
cy, while keeping the feature that some events must be completed before
others can occur. A general process of this type can be described as an
event tree, explicitly enumerating the possible sequences of events that
Universality of J-shaped and U-shaped Dose Response Relations as Emergent Properties
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take a normal stem cell to a malignant one. Each node in the tree corre-
sponds to the sequence of events that have occurred so far, and the suc-
cessors of each node are the events that can occur next, corresponding to
branches out of the current node. The branch probabilities at each node
complete the specification of the process. (A directed acyclic graph
(DAG) indicating allowed transitions among events, along with their
probabilities, i.e., a stochastic transition network (STN), often provides a
more concise representation of the same information. However, the tree
provides a clear, useful conceptual model of multiple alternative paths
and precedence partial ordering constraints among events.) 
The time at which a malignant cell is first formed can be interpreted
as a first passage time (Harrison and Knottenbelt, 2001) through the tree
or through its corresponding stochastic transition DAG. Let x(t) indicate
which nodes or which transition arcs have been traversed by time t, and
let F(x) indicate whether a tip of the tree (or a “malignant” node) has
been reached when the state is x. Then x(t) is monotonically increasing
in time, part (a) of Theorem 2 holds, and there is a finite transition inter-
val that contains the first passage time, i.e., the probability that the first
malignant cell has been formed essentially goes from 0 to 1 over this
interval. The transition need not be sharp, however, unless the event tree
has internal symmetries. The total symmetry in part (b) of Theorem 2 is
stronger than necessary. For example, if there is a sharp threshold for the
time to bring a cell from node A to node B in a DAG (via any of several
paths), and another sharp threshold for the time to bring it from B to C,
then there is a sharp threshold for the passage time from A to C, despite
the asymmetries that A precedes B and B precedes C. 
More generally, Theorem 2 can be strengthened and extended in sev-
eral ways to apply to more general classes of systems, e.g., to characterize
the distribution of first-passage times through transition graphs that are
not necessarily acyclic, but that eventually lead to malignancy, starting
from any other node, with probability 1. Such models can allow for some
reversible transitions, e.g., reflecting fallible repair processes. However,
Theorem 2 suffices for several interesting applications. 
3. APPLICATIONS TO CARCINOGENESIS
In the MVK two-stage model of carcinogenesis, each of N normal
stem cells may undergo initiation. Initiated stem cells may die, replicate,
or undergo an additional transformation to become malignant. It is usu-
ally assumed that exposure results in biologically effective doses that
increase the rates of initiation, initiated cell birth or death (e.g., promo-
tion or apoptosis, respectively), and transformation of initiated to malig-
nant cells (progression) in proportion to the dose. The transition inter-
val framework in Theorem 2 suggests some alternatives to this propor-
tional-increase assumption. In particular, rather than essentially unpre-
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dictable (exponentially distributed) transition times for each cell, transi-
tion times may be confined to certain highly probable intervals, with the
widths of these intervals being small in some situations, e.g., for transi-
tions described by monotone symmetric functions of many independent,
identically distributed Bernoulli random variables. 
Suppose that, for a given exposure history, exposure-induced initia-
tion of susceptible stem cells can occur in the transition interval (t1, t2),
i.e., between ages t1 and t2 years, while progression to malignancy is like-
ly to take an additional amount of time of between t3 and t4 years, cor-
responding to a transition interval of length t4 – t3. [Both initiation and
malignancy are here considered as irreversible events in the stochastic
evolution of a cell (or somatic cell line) from normalcy to malignancy,
and the conditions of part (a) of Theorem 2 are satisfied, so that there is
a transition interval for each event.] If further observations are censored
by death at time T, then the probability density for the time of a malig-
nant cell being formed prior to death will be concentrated in the interval
[min{t1 + t3, T}, min{t2 + t4, T}]. Thus, if t1 + t3 > T, malignant cells will
not arise; if t2 + t4 < T, then malignant cells may arise prior to t2 + t4, but
not at older ages, i.e., the hazard rate decreases with older ages past some
point, reaching 0 at age t2 + t4. Attaining this age without a malignant cell
implies that no susceptible cells entered the pipeline during (t1, t2), so
that none will emerge as malignant cells after t2 + t4. In all other cases,
malignant cells may arise throughout old age, beginning at age t1 + t3
and continuing until death. 
In this framework, exposure to carcinogens can have any of the fol-
lowing effects: 
1. Reduce t1 and t2, i.e., shift the initiation interval between them [t1, t2],
leftward toward earlier ages, by completing one or more of the trans-
formations required for a normal cell to become initiated. If the num-
ber of such transformations, K, is small, then only a few such discrete
leftward shifts are possible, corresponding to different transforma-
tions that can be completed by the carcinogen. Each such shift sto-
chastically decreases (Ross, 1996) the remaining time to malignancy.
2. Shift the progression interval [t3, t4] leftward. This occurs if the expo-
sure completes one or more transformations in an initiated cell, sto-
chastically decreasing the remaining time until first passage of that
cell (or its progeny) to malignancy.
3. Amplify the population of initiated cells. If each initiated cell has proba-
bility P of becoming malignant before death at time T, perhaps by tra-
versing some path through a complicated stochastic transition net-
work, then a population of I initiated cells has probability 1 – (1 – P)I
of generating at least one malignant cell before T. Thus, increasing I
increases the lifetime probability of cancer. 
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4. Amplify the population of normal stem cells that are susceptible to initiat-
ing transitions. Cytotoxic effects on normal cell populations, which
typically have concentration and/or AUC thresholds, can lead to
compensating proliferation of normal stem cells and increased flux
(after a delay of t2 – t1) into the initiated compartment, again
increasing the average value of I. 
5. Combinations of the above.
If the exposure-driven transitions in (1) or (2) themselves have sharp
transition thresholds for an exposure variable such as AUC, i.e., if they
occur with high probability if and only if dose exceeds some critical level,
AUC* ppm-hours per day, as in the receptor-mediated response example
above, then the possible discrete leftward shifts in [t1, t2] will be trig-
gered by exposures above this threshold, and otherwise will not occur.
There may be several different such dose-response thresholds. This
threshold behavior for increases in risk might generate data similar to the
pattern for histiosarcomas and lung carcinomas seen in Table 1, having
an apparent concentration threshold between 140 ppm and 280 ppm for
8-hour/day exposures. 
Importantly for practical data analysis, the increased risk from expo-
sure in this transition interval framework is only sensitive to details of
exposure (e.g., the concentration) over the range of the transition inter-
val(s): otherwise, details of exposure are irrelevant for predicting
response. All that matters is which events get triggered with high proba-
bility by the exposure pattern.
U-Shaped Dose-Response Relations 
Suppose that a normal stem cell (or somatic cell line) must success-
fully traverse a stochastic transition network (STN) to become malignant.
Paths through the network correspond to sequences of events that trans-
form a normal genotype to a malignant one. The network may consist of
two or more stages, e.g., first with multiple possible paths leading from
normal to initiated, and then with multiple other paths leading from ini-
tiated to malignant. While such a staged structure can potentially simpli-
fy analysis of the effects of exposures on the distribution of first passage
times through the network, it is not necessary for the following analysis.
Consider the fates of normal stem cells with finite lifetimes, T (e.g.,
due to apoptosis, cytotoxic exposures, clonal succession, etc.) entering the
STN. (T may be a random variable, with different realized values for dif-
ferent cells.) Starting from the initial node, which might be called NOR-
MAL, each cell progresses through the network by making stochastic tran-
sitions, eventually reaching the final node (MALIGNANT) with some
probability unless it dies or differentiates first, i.e., unless elapsed time T
occurs before malignancy. In this setting, any condition that shortens T
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(or stochastically reduces it, if T is a random variable), including exposure
to a cytotoxic carcinogen, will tend to reduce the probability of successful
traversal of the network, other things (i.e., transition rates) being held
equal. In contrast to K-stage models in which exposure can only hasten the
transition of cells toward malignancy, in this framework, exposure can
reduce the probability that a cell survives to reach malignancy. 
For example, if an increase in weeks of exposure decreases T, e.g., by
increasing the probability of cell death per week, but without further
increasing transition rates in the STN (e.g., due to the threshold effects
described above, and because exposure intensity in ppm-hours/day
remains unchanged), then the increase in weeks of exposure would reduce
the probability of carcinogenesis per normal stem cell entering the STN.
If this reduction outweighs any increase in the flux of normal stem cells
entering the STN per unit time to compensate for reduced T, then the
net result would be a reduced risk of malignant cells. For example, if the
number of cells per unit time increases homeostatically just enough to
offset the shorter life per cell, thus maintaining cell population sizes,
then the lifetime risk of cancer could be reduced, with a larger number
of shorter-lived cells having less probability of successfully percolating
through the STN than a smaller number of longer-lived cells. Such a phe-
nomenon might be consistent with the observed reduction in lung and
other adenomas in Table 1 between groups 3 and 4 if the time scale for
first passage times through the STN is on the order of days to weeks.
Group 4 has twice the weeks of exposure of group 3, yet a significantly
lower rate of adenomas. (The difference is not due to censoring by early
mortality, as these doses are well below lethal levels.) To test the hypo-
thetical explanation that this is because T is reduced, one might investi-
gate the cell kinetics (average life spans and fluxes) of affected cell pop-
ulations to determine whether the average life spans per cell are in fact
significantly reduced by additional weeks of exposure. 
In STNs where relatively many stem cells traverse the first few nodes
and relatively few penetrate much deeper into the network, energetically
costly defenses (e.g., detection and repair or apoptosis mechanisms for
damaged cells) may tend to be distributed primarily among the most fre-
quently traversed, early nodes. In effect, if blocking cancer confers some
evolutionary advantage, then defenses that block a high proportion of
potential cancers may have been selected, while lower-payoff late defens-
es may not. In this case, exposures that reduce T, tending to keep cells in
the earlier, relatively well-defended parts of the STN, may be especially
likely to reduce cancer risk. Expressed in terms of an MVK two-stage
model, U-shaped dose-response relations can arise not only by exposures
that kill initiated cells (Holt, 1997; Bogen, 2001), but also by exposures
that inhibit the fluxes of normal to initiated cells and/or of initiated to
malignant cells.
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4. CONCLUSIONS
We have presented a generalization of stochastic transition models of
carcinogenesis that replaces the individual transitions in such models
(e.g., from normal to initiated cells or from initiated to malignant cells)
with stochastic transition networks (STNs). Exposures can affect cells not
only by linearly increasing transition rates and by amplifying initiated
and/or normal stem cell populations (as in Holt, 1997), but also by caus-
ing some transitions to happen with certainty (in effect, making their
rates infinite) and by shortening the time T that cells have to complete a
passage through the STN before dying or differentiating. More general-
ly, we have considered models in which facts about a cell or cell line (or
other system) can become true at random times, and malignancy occurs
as soon as some subset of facts has become true, analogous to a minimal
path set in systems reliability theory. There may be many different subsets
of facts that jointly suffice to entail malignancy, and the first one com-
pleted then determines the time at which a malignant cell is first formed.
Within this framework, we applied known results from random graph
theory to deduce two useful mathematical properties: (1) The existence
of a finite transition interval for occurrence of malignancy (or for the first
passage time of a normal cell through an STN), with the probability of
malignancy increasing from 0 to 1 (to any desired degree of precision)
over that interval; and (2) The existence of sharp thresholds for transitions,
i.e., transition intervals whose widths approach zero, for systems with
global symmetry and large numbers of components. We observed that
the symmetry condition is needlessly strong, i.e., sharp transition thresh-
olds may hold even in multistage (asymmetric) models with STNs rather
than single transitions between consecutive stages, provided that each
STN has a sharp transition threshold. These results also hold for transi-
tions expressed as functions of exposure concentration, or AUC (ppm-
hours) per day of exposure, as well as for time.
The STN and transition interval framework developed in this paper
predicts the possibility of some qualitative behaviors seen in stop-expo-
sure experimental data for chemical carcinogens. These include:
• The possibility of age-specific hazard functions that decrease with age
after some point.
• Sharp threshold or more gradual “J-shaped” portions of dose-response
curves, where response probabilities increase suddenly as exposure
concentration or hours-per-day of exposure increase relatively slightly
near a critical threshold value (e.g., histiosarcomas between 140 ppm
and 280 ppm in Table 1.) 
• Flat, L-shaped, or U-shaped relations between total dose and risk, when
increasing weeks of exposure has little effect or even suppresses cancer
risk (as for groups 3 and 4 in Table 1. See also groups 7 and 8 for what
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may be a combination of a J-shaped response to hours-per-day of expo-
sure, and hence to ppm-hours/day, with a flat or U-shaped response to
weeks of exposure.) 
The possibility of these qualitative behaviors emerges from relatively sim-
ple, high-level assumptions about the stochastic transition networks and
resulting transition intervals involved. For example, the sharp transition
threshold results based on monotonicity, symmetry and a requirement
that large numbers of binary facts must hold (exemplified by k-out-of-n
receptor sites becoming bound within a certain time window) are univer-
sal, in that they do not depend on the details of the facts in any way. 
The main practical message from the mathematical modeling in this
paper is that the abrupt transitions and multi-threshold type behaviors
observed in some experimental cancer dose-response data can be
explained as a natural consequence (an emergent property) of the com-
plexity of pathways leading to carcinogenicity, even when individual
events at the cell level occur at rates that vary slowly and smoothly (e.g.,
linearly) with exposure. When transitions from one cell type to the next
can occur in many different ways, so that each transition can be thought
of as a passage through a network with many possible paths through it,
this complexity can result in abrupt transitions of the probability of suc-
cessful passage through the network as a function of exposure or dose.
Such abrupt transitions are an emergent property of a wide class of sto-
chastic transition network models. The idea that complexity of possible
transitions toward carcinogenesis can explain abrupt dose-response tran-
sitions is especially relevant for cancers with complex, stochastic etiolo-
gies, as indicated by tumors with different profiles of accumulated dam-
age and no small set of necessary and sufficient changes. These include
lung cancers (Wistuba et al., 2001) and other cancers of importance in
public health.
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